Michael Martin currently serves as the President and CEO of Plexium since January 2024. Prior to this role, Michael held multiple leadership positions at Takeda, including Head of the Center for External Innovation and work with Takeda Ventures, Inc. from 2015 to January 2024. Michael's expertise in global licensing and business development was developed during tenure at Takeda Pharmaceuticals from 2012 to 2015, where responsibilities included heading the Intellikine integration. Earlier experiences also include positions at Intellikine Inc., TargeGen, Inc., and Arena Pharmaceuticals, showcasing a robust background in the biotechnology and pharmaceutical sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices